Home › Research › Lewy body dementia
Exploring the Role of microRNAs as Blood Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia
Irene Petracci, Sonia Bellini, Katarzyna Goljanek‐Whysall, Leo R. Quinlan, Agnieszka Fiszer, Ali Çağlar Çakmak, Cyrille Mesue Njume, Barbara Borroni et al.. International Journal of Molecular Sciences, 2025-04-05
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Alzheimer's disease (AD) and frontotemporal dementia (FTD) are the most common forms of dementia globally. AD is characterized by the accumulation of amyloid-β (Aβ) plaques and hyperphosphorylated tau in the brain, leading to progressive memory loss and cognitive decline, significantly impairing daily life. In contrast, FTD is marked by selective degeneration of the frontal and/or temporal lobes, typically resulting in profound changes in personality and social behavior, speech disorders, and psychiatric symptoms. Numerous studies have found microRNAs (miRNAs)-small, non-coding RNA molecules that regulate gene expression post-transcriptionally-to be dysregulated in AD and FTD. As a result, miRNAs have emerged as promising novel biomarkers for these diseases. This review examines the current understanding of miRNAs in AD and FTD, emphasizing their potential as accessible, noninvasive biomarkers for diagnosing these prevalent neurodegenerative disorders.
What this study adds
Evidence grade: Low
This review examines microRNAs as promising novel biomarkers for Alzheimer's disease and frontotemporal dementia, emphasizing their potential as accessible, noninvasive tools for diagnosing these disorders. No diagnostic or treatment application is yet established.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Petracci, I., Bellini, S., Goljanek‐Whysall, K., Quinlan, L. R., Fiszer, A., Çakmak, A. Ç., et al. (2025). Exploring the Role of microRNAs as Blood Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073399
Vancouver
Petracci I, Bellini S, Goljanek‐Whysall K, Quinlan LR, Fiszer A, Çakmak AÇ, et al. Exploring the Role of microRNAs as Blood Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073399. PMID: 40244285.
BibTeX
@article{petracci2025-40244285,
author = {Petracci, Irene and Bellini, Sonia and Goljanek‐Whysall, Katarzyna and Quinlan, Leo R. and Fiszer, Agnieszka and Çakmak, Ali Çağlar and Njume, Cyrille Mesue and Borroni, Barbara and others},
title = {{Exploring the Role of microRNAs as Blood Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia}},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26073399},
pmid = {40244285},
url = {https://doi.org/10.3390/ijms26073399}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- AD is characterized by the accumulation of amyloid-β (Aβ) plaques and hyperphosphorylated tau in the brain, leading to progressive memory loss and cognitive decline, significantly impairing daily life.
- As a result, miRNAs have emerged as promising novel biomarkers for these diseases.
Why it matters
This review examines microRNAs as promising novel biomarkers for Alzheimer's disease and frontotemporal dementia, emphasizing their potential as accessible, noninvasive tools for diagnosing these disorders. No diagnostic or treatment application is yet established.
Study details
- Evidence strengthLow
How this study scored 45/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (International Journal of Molecular Sciences) |
| Journal's citation record | 3 / 4 | International Journal of Molecular Sciences: journal h-index 426 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 15 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 5.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 5.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 2 / 4 | Cited 15 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Roberta Ghidoni: h-index 65 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Liverpool: institution h-index 995 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 6 institution(s) in 5 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40244285) |
| Free to read | 2 / 2 | Free to read |
| Total | 45 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3390/ijms26073399
- PubMed: 40244285
- Original source →
- Free full text: International Journal of Molecular Sciences →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Lewy body dementia from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.